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Case Report
Horner’s Syndrome with Abducens Nerve Palsy
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A 68-year-old male patient presented with a week of sudden diplopia. He had been diagnosed with nasopharyngeal 
cancer 8 months prior and had undergone chemotherapy with radiotherapy. Eight-prism diopter right esotropia in 
the primary position and a remarkable limitation in abduction in his right eye were observed. Other pupillary dis-
orders and lid drooping were not found. After three weeks, the marginal reflex distance 1 was 3 mm in the right eye 
and 5 mm in the left eye. The pupil diameter was 2.5 mm in the right eye, and 3 mm in the left eye under room 
illumination. Under darkened conditions, the pupil diameter was 3.5 mm in the right eye, and 5 mm in the left eye. 
After topical application of 0.5% apraclonidine, improvement in the right ptosis and reversal pupillary dilatation were 
observed. On brain magnetic resonance imaging, enhanced lesions on the right cavernous sinus, both sphenoidal 
sinuses, and skull base suggested the invasion of nasopharyngeal cancer. Lesions on the cavernous sinus need to 
be considered in cases of abducens nerve palsy and ipsilateral Horner’s syndrome.
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The cavernous sinus is a structure located near the center 
of the skull base, that is situated bilaterally on the medial side 
of both sphenoid sinuses [1,2]. It contains the oculomotor, 
trochlear, abducens, and the first two divisions of the tri-
germinal nerve as well as the oculosympathetic nerve plexus 
around the internal carotid artery [3-6]. These anatomical 
particularities are causes of solitary or combined diverse im-
pairments of cranial nerves and postganglionic Horner’s syn-
drome [1,3,4,7]. Tumour involvement of the cavernous sinus 
region due to distant metastasis or local extension has been 
reported in <1% of cancer patients [3,7]. Furthermore, the 
brain is a rarely involved site with head and neck cancers 
[3,8,9]. Nasopharyngeal carcinoma can spread through the 
foramen lacerum and invade the cavernous sinus, resulting in 
cranial nerve injuries [7]. In previous reports, there have been 
only 13 cases of combined abducens nerve palsy and ipsi-
lateral Horner’s syndrome secondary to metastatic neoplasm 
within the cavernous sinus [4,10-16]. Here, we report a case 
with a combination of 6th nerve palsy and incomplete 
Horner’s syndrome caused by invasive nasopharyngeal can-
cer in the cavernous sinus.
Case Report
We examined a 68-year-old man who had been suffering 
from diplopia for a week. The patient had been diagnosed 
with a nasopharyngeal squamous cell carcinoma 8 months 
prior and had received cisplantin-based chemotherapy with 
radiotherapy. On the first examination, 8-prism diopter right 
esotropia in the primary position and a remarkable limitation 
in abduction in his right eye were observed. Other pupillary 
disorders and lid drooping were not found (Fig. 1). After 3 
weeks, the patient complained of lid drooping in the right 
eye. The marginal reflex distance 1 (MRD1) was 3 mm in the 
right eye and 5 mm in the left. In addition to right mild ptosis, 
anisocoric pupils with a smaller right pupil were found and 
the anisocoria increased in the dark. After topical application 
of 0.5% apraclonidine (Iopidine; Alcon, Fort Worth, TX, 
USA), the patient’s right pupil dilated from 2.5 mm to 5 mm 
in bright light and the right MRD1 increased from 3 mm to 5 
mm (Fig. 2). Hypohydrosis and other neurologic abnormal-
ities were not observed. Brain magnetic resonance imaging 
(MRI) revealed newly appeared gadolinium-enhanced mu-
cosal thickening in both sphenoid sinuses combined with bo-
ny destruction of the skull base. These lesions extended to the Korean J Ophthalmol Vol.25, No.6, 2011
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Fig. 1. Ocular movements. 
Right esotropia and limi-
tation of abduction in the 
right eye consistent with 
right abducens nerve palsy 
were observed. 
C1  C2
A1  A2   B1 B2
Fig. 2. (A1,B1) Before topical application of 0.5% apraclonidine in room light. Pupil right eye (OD) measured 2.5 mm (A1), pupil left eye 
(OS) measured 3.0 mm (B1). (A2,B2) After topical application of 0.5% apraclonidine in bright light. Pupil OD measures 5.0 mm (A2), pupil 
OS measured 4.0 mm (B2). Reversal of pupillary dilatation under topical application of 0.5% apraclonidine was detected. (C1,C2) Note also 
the improvement of the mild ptosis in the right side after topical application of 0.5% apraclonidine.
right cavernous sinus with encasement of the internal carotid 
artery (ICA) (Fig. 3). The patient underwent bilateral func-
tional endoscopic sinus surgery with biopsy. Pathology was 
consistent with poorly differentiated invasive squamous cell 
carcinoma (Fig. 4). Seven weeks later, the esotropia wors-
ened and the limitation of abduction, anisocoria, and right 
ptosis persisted. No other neurologic abnormalities were 
found up to the last visit. The patient died of cancerous cachex-
ia 15 months after the diagnosis of nasopharyngeal cancer.
Discussion
Neither abducens nerve palsy nor Horner’s syndrome pro-
vides an indication of the location of the lesion. However, 
when both are present, it is important to localize the site of 
the lesion [16]. When these rare clinical features are man-
ifested, we have to consider paratrigerminal syndrome or a 
lesion of the posterior cavernous sinus [1]. Sympathetic 
nerve fibers travel over the wall of the carotid artery and in 
the cavernous portion the fibers leave the ICA and accompany 
the abducens nerve for only a few millimeters in the posterior 
portion of the sinus [4,10,12,16] (Fig. 5). Therefore, we could 
consider a posterior cavernous sinus lesion due to combined 
abducens nerve palsy. Furthermore, incomplete Horner’s 
syndrome without anhydrosis, as in the case reported here, 
indicates the involvement of the periarterial sympathetic 
plexus at the third angulation point [17]. To date, only 13 cases 
with this combination of symptoms secondary to metastatic NH Kang, et al. Horner’s Syndrome with Abducens Nerve Palsy
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Fig. 3. Axial T1-weighted contrast-enhanced magnetic resonance 
images. Ill-defined right cavernous sinus lesion extending into the 
sphenoidal sinus and encasement of the internal carotid were found.
Fig. 4. A photomicrograph of the frozen biopsy during the func-
tional endoscopic sinus surgery showing the moderately to poorly 
differentiated squamous cells in the right sphenoid sinus (H&E, ×200).
Fig. 5. Schematic drawing demonstrating the anatomy of the poste-
rior portion of the cavernous sinus on the right side. Oculosympathetic 
nerve fibers leave the internal carotid artery, and then join the abdu-
cens nerve for a short distance in the posterior portion of the cav-
ernous sinus (arrow). CN III = oculomotor nerve; CN IV = troch-
lear nerve; CN V = trigeminal nerve; ICA = internal carotid; CN 
VI = abducens nerve; Sym = oculosympathetic nerve.
neoplasm within the cavernous sinus have been reported 
[4,10-16]. Regarding the primary lesions in these cases, there 
were 1 small cell lung cancer [10], 1 parotid cancer [10,12], 1 
breast cancer [11], 1 gastric cancer [10], 1 uterine cancer [4], 
3 undetermined origins [13,14] and 3 nasopharyngeal can-
cers [15]. Unlike in other three nasopharyngeal cancer cases 
reported by Hirao et al. [15], the cancer only invaded the 6th 
nerve and sympathetic fiber without involvement of the 5th 
nerve in this case. Malignant tumors that affect the cavernous 
sinus commonly result in the 5th and the 6th
 nerve injuries 
[3,8]. The more medial location of the abducens nerve has 
been postulated as the reason for its frequent involvement 
when confronted with the compressive forces in a confined 
space or direct invasion [8]. In this case, the nasopharyngeal 
cancer extended through the sphenoidal sinus demonstrated 
by brain MRI and positron emission tomography (Fig. 3). 
Therefore, the cancer affected only the 6th nerve without in-
volvement the 3rd nerve, which occupies a superior position 
at the lateral wall of the sinus, in addition to the 4th and 5th 
nerve [1]. Although autopsy was not permitted and there was 
a limitation of anatomical access, we suggest that tumor cells 
in the sphenoidal sinus had spread to the 6th nerve in the cav-
ernous sinus, and then perineurally metastasized to the ocu-
losympathetic nerve fibers before joining the first division of 
the 5th nerve [3]. A plausible alternative to cocaine or hy-
droxyamphetamine in the diagnosis of Horner’s syndrome is 
apraclonidine, a direct α-receptor agonist with strong α2 and 
weak α1 activity [18]. In patients with Horner’s syndrome, 
reversal of anisocoria and improvement of ptosis occur after 
application of apraclonidine due to denervation supersensitivity 
of the α1 receptor [18]. With respect to the length of survival 
in patients with tumor invasion of the cavernous sinus region 
as reported in the literature, most individuals live no longer 
than six months and the ultimate outcome is a dismal 75% to 
85% expected mortality within 2 years [3,8]. The patient described 
in this report died 5 months after the presentation of combi-
nation abducens nerve palsy with Horner’s syndrome. In oth-
er words, this manifestation may be a significant predictor of 
survival in addition to the location of the lesion. This is the 
first reported case of abducens nerve palsy with Horner’s 
syndrome due to tumor invasion into the cavernous sinus in a 
Korean patient. The presence of Horner’s syndrome and the 
6th nerve palsy should be cautiously investigated to confirm 
the existence of the cavernous sinus lesions.
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